ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3137

Scleroderma Hand Contracture Study

Joyce Joseph, Rheumatology, Univeristy of Teas Health Science Center at Houston, Houston, TX

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Hand function and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: To investigate the progression of hand contractures in patients with systemic sclerosis and to identify disease features predictive of contractures. A sub-group analysis was also performed on patients with less than or equal to 2 years since disease onset.

Methods: Patients enrolled in the GENISOS cohort were assessed for disease features predictive of hand contractures. Such variables are included in Table 1. 

Linear mixed model was used to analyze longitudinal measurements of each hand separately given the potential for variation in the extent of contracture development. The time variable is the date of first non-Raynaud’s symptom.

A subgroup analysis was also performed with the same disease variables to assess for predictive features and to assess if the rate of decline was faster earlier in disease.

Results: 1108 sets of hand measurements were evaluated over a median follow-up period of 8.8 years. 219 patients were included in the analysis and 62 patients in the subgroup analysis. In the right hand, ATA and MRSS scores were predictive of a decrease in hand extension. ATA positive patients showed a decrease in right hand extension by 0.24 cm/year while ATA negative patients showed a decrease in hand extension by 0.075 cm/year. A similar decrease in hand extension was observed in the left hand for ATA positive patients.

A unit increase in the MRSS score was predictive of faster decline in right hand extension by 0.006 cm/yr.

In the subgroup analysis, disease type and ACA were predictive of contracture development in the right hand. Patients with diffuse disease were found to have a decrease in right hand extension by 0.64 cm/year. ACA negative patients were found to have a decrease in hand extension by 0.21 cm/yr in the right hand.

In the left hand, ATA, ACA and digital ulcers were predictive of contracture development. ATA positive patients showed a decrease in left hand extension by 1.54 cm/year while ATA negative patients showed a decrease in hand extension by 0.08 cm/year. Further, the absence of digital ulcers was also predictive of decrease in hand extension in the left hand.

Conclusion:  This is the largest and longest reported prospective study assessing disease features predictive of hand contractures in patients with systemic sclerosis.

ATA and MRSS scores were predictive of hand contracture development in the right hand. ATA was also predictive of hand contracture development in the left hand. Discrepancy in skin score as a predictor between the two hands may be related to hand dominance.

Disease Variable

Right hand rate of change

p-value

Left hand rate of change

p-value

Topo positive

-0.2354

0.037

-0.2791

0.0025

Topo negative

-0.0751

 

-0.0523

 

ACA positive

 -0.0312

0.4399

-0.0293

0.4799

ACA negative

-0.1166

 

-0.1072

 

RNA pol 3 positive

-0.112

0.964

-0.0848

0.7469

RNA pol 3 negative

-0.109

 

-0.1075

 

Diffuse disease

-0.1153

0.8127

-0.118

0.5288

Limited disease

-0.1001

 

-0.0781

 

Digital ulcers present

-0.1327

0.6714

-0.0783

0.6581

Digital ulcers absent

-0.1017

 

-0.1102

 

Small joint arthritis present

-0.1233

0.7401

-0.1418

0.368

Small joint arthritis absent

-0.1009

 

-0.0819

 

Baseline MRSS

-0.0056

0.0407

-0.0048

0.076

FVC percent predicted

0.0004

0.784

0.0009

0.547

Subgroup Analysis

Disease Variable

Right hand rate of change

p-value

Left hand rate of change

p-value

Topo positive

-0.495

0.41

-1.5363

0.015

Topo negative

-0.0123

 

-0.0822

 

ACA positive

1.287

0.038

 1.206

0.027

ACA negative

-0.210

 

 -0.446

 

RNA pol 3 positive

0.5276

0.19

-0.343

0.76

RNA pol 3 negative

0.0773

 

-0.195

 

Diffuse disease

-0.637

0.003

 -0.6271

0.092

Limited disease

0.524

 

0.0737

 

Digital ulcers present

0.066

0.67

0.456

0.046

Digital ulcers absent

-0.142

 

-0.524

 

Small joint arthritis present

-0.4235

0.37

-0.745

0.24

Small joint arthritis absent

0.0112

 

-0.156

 

Baseline MRSS

-0.0291

0.099

-0.0138

0.45

FVC percent predicted

-0.0141

0.169

0.00897

0.41

 


Disclosure: J. Joseph, None;

To cite this abstract in AMA style:

Joseph J. Scleroderma Hand Contracture Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/scleroderma-hand-contracture-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/scleroderma-hand-contracture-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology